Aryloxyarylsulfonylamino hydroxamic acid derivatives
US6214872A · kind A · utility
70Cited by
1References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 26, 1999 |
| Grant date | Apr 10, 2001 |
| Priority date | — |
| Expiry date | Aug 26, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D309/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of the formula ##STR1## PA1 wherein X, Y, R.sup.1 and R.sup.2 are as defined above, useful in the treatment of arthritis or cancer and other diseases involving selective inhibition of matrix metaloproteinase-13.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.